Article

Higher Doses of Vitamin D Can Lower Incidence of Respiratory Infection

Author(s):

Recently, researchers from the University of Colorado Anschutz Medical Campus discovered high doses of vitamin D helped older, long-term care residents reduce the risk of acute respiratory illness (ARI).

Many physicians have long considered vitamin D to have a myriad of health benefits, recommending patients to take supplements or increase their intake of vitamin D-enriched foods. And, recently, researchers from the University of Colorado Anschutz Medical Campus discovered high doses of vitamin D helped older, long-term care residents reduce the risk of acute respiratory illness (ARI).

Published in the Journal of the American Geriatrics Society, the results were especially relevant, as this discovery could help decrease one of the primary causes of debilitation and death among patients in nursing homes and long-term care facilities.

The study’s lead author, Adit Ginde, MD, MPH, said in a news release, “After studying these patients for a year, we found a 40% reduction in acute respiratory illness among those who took higher doses of vitamin D.”

To examine vitamin D’s impact on respiratory infections in nursing home residents, the team assessed 107 patients, whose age averaged 84 years, during a 12-month period. Of that group, 55 received high doses of vitamin D (100,000 units monthly or 3,300-4,300 units daily). The remaining 52 were administered standard doses averaging between 400-1,000 units daily. Members of the higher dosage group experienced an approximately 50% reduction in ARIs; however, they also had more than double the incidence of falls.

According to Ginde, vitamin D actually works to improve the immune system’s ability to fight infections, since it boosts the immune system’s first line of defense — something that is often impaired in geriatric patients. However, vitamin D can also potentially prevent illnesses like pneumonia, influenza, and bronchitis. Furthermore, higher vitamin D doses could prevent infections and aggravations of asthma, COPD, and emphysema.

While higher vitamin D doses did seemingly reduce the risk of ARI and other respiratory illness, experts cautioned, “This finding requires a confirmatory trial, including whether high daily doses of vitamin D, rather than high monthly doses, make patients less likely to fall.”

Regardless, this is an important discovery, allowing specialized treatment for the elderly in long-term care.

Related Coverage:

Vitamin D Supplements Improve Bone Turnover Markers in Postmenopausal Women

Vitamin D Deficiency Is Significantly More Common in People with Noninfectious Uveitis

Maternal Vitamin D Has Impact on Kids Atopic Dermatitis

Related Videos
How to Manage Aspirin-Exacerbated Respiratory Disease
Safety Data on Dupilumab, Ensifentrine for COPD, with MeiLan Han, MD
MeiLan Han, MD: Discussing Updates on Dupilumab, Ensifentrine in 2025 GOLD Report
Physician, Patient, and Partner Perspectives on AERD with Mitchell Grayson, MD, Rhonda Nelson, and Wayne Nelson
Monica Kraft, MD: Discussing Phase 3b Findings on Albuterol/Budesonide for Asthma
How Artificial Intelligence is Being Used in Lung Imaging, with Rachel Eddy, PhD
Developing Risk Assessment Tools for Viruses in School
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
What Do Patients Need to Learn About their Hypersensitivity Pneumonitis?
© 2024 MJH Life Sciences

All rights reserved.